Zolbetuximab
- Generic Name
- Zolbetuximab
- Brand Names
- Vyloy
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1496553-00-4
- Unique Ingredient Identifier
- TF5MPQ8WGY
- Background
Zolbetuximab is under investigation in clinical trial NCT01630083 (Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 252
- Registration Number
- NCT01630083
- Locations
- 🇷🇺
Site RUS009, Kursk, Russian Federation
🇺🇦Site UKR003, Dnipropetrovsk, Ukraine
🇺🇦Site UKR007, Kyiv, Ukraine
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Ganymed Pharmaceuticals GmbH
- Target Recruit Count
- 54
- Registration Number
- NCT01197885
- Locations
- 🇧🇬
Complex Oncology Center, Veliko Turnovo, Bulgaria
🇧🇬MHAT "St.Marina", Varna, Bulgaria
🇩🇪Universitätsklinikum Halle, Halle, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath